A Study to Evaluate C-CAR031 in Glypican-3 (GPC3)+ Advanced/Recurrent Hepatocellular Carcinoma (HCC)

NCT06590246 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

BIOLOGICAL: Armored and GPC3-targeted autologous CAR T-cell

Sponsor

Shanghai AbelZeta Ltd.